Bio­phar­ma com­pa­nies pledge $1B to fund an­tibi­otics R&D as field shriv­els; Four biotechs hunt $797M+

→ As promised, a group of some 20 bio­phar­ma com­pa­nies have pooled close to $1 bil­lion to fund new re­search …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.